Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes

Background/Objectives: This study aimed to assess the incidence of diabetic retinopathy (DR) in patients with type 2 diabetes (T2DM) treated in primary-care settings in Catalonia, Spain, and identify key risk factors associated with DR development. Methods: A retrospective cohort study was conducted...

Descripción completa

Detalles Bibliográficos
Autores: Hernández-Teixidó, Carlos, Barrot de la Puente, Joan|||0000-0002-7482-7647, Miravet Jiménez, S., Fernández-Camins, Berta|||0000-0001-7535-6181, Mauricio, Didac|||0000-0002-2868-0250, Romero Aroca, P., Vlacho, Bogdan|||0000-0003-3768-8112, Franch-Nadal, Josep|||0000-0002-5175-1555
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:310168
Acceso en línea:https://ddd.uab.cat/record/310168
https://dx.doi.org/urn:doi:10.3390/jcm13237083
Access Level:acceso abierto
Palabra clave:Diabetic retinopathy
Incidence
Microvascular complications
Primary care
Type 2 diabetes mellitus
Descripción
Sumario:Background/Objectives: This study aimed to assess the incidence of diabetic retinopathy (DR) in patients with type 2 diabetes (T2DM) treated in primary-care settings in Catalonia, Spain, and identify key risk factors associated with DR development. Methods: A retrospective cohort study was conducted using the SIDIAP (System for Research and Development in Primary Care) database. Patients aged 30-90 with T2DM who underwent retinal screening between 2010 and 2015 were included. Multivariable Cox regression analysis was used to assess the impact of clinical variables, including HbA1c levels, diabetes duration, and comorbidities, on DR incidence. Results: This study included 146,506 patients, with a mean follow-up time of 6.96 years. During this period, 4.7% of the patients developed DR, resulting in an incidence rate of 6.99 per 1000 person-years. Higher HbA1c levels were strongly associated with an increased DR risk, with patients with HbA1c.